Author:
Khalimova K. M.,Rashidova N. S.,Salimjonov J. J.
Publisher
Springer Science and Business Media LLC
Reference86 articles.
1. WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19, March 11, 2020, https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020.
2. Anderson, E. J., Rouphael, N. G., Widge, A. T., et al., “Safety and immunogenicity of SARSCoV-2 mRNA-1273 vaccine in older adults,” N. Engl. J. Med., 383, 2427–2438 (2020), https://doi.org/10.1056/NEJMoa2028436.
3. Jackson, L. A., Anderson, E. J., Rouphael, N. G., et al., “An mRNA vaccine against SARS-CoV-2. Preliminary report,” N. Engl. J. Med., 383, 1920–1931 (2020), https://doi.org/10.1056/NEJMoa2022483.
4. Sadoff, J., Gray, G., Vandebosch, A., et al., “Safety and efficacy of single-dose Ad26.COV2.S vaccine against COVID-19,” N. Engl. J. Med., 384, 2187–2201 (2021), https://doi.org/10.1056/NEJMoa2101544.
5. Walsh, E. E., Frenck, R. W., Falsey, A. R., et al., “Safety and immunogenicity of two RNA-based COVID-9 vaccine candidates,” N. Engl. J. Med., 383, No. 2450, 2439–5240 (2020), https://doi.org/10.1056/NEJMoa2027906.